While the world waits for a vaccine against SARS-CoV-2 – the novel coronavirus that causes COVID-19 – one likely control and exit strategy is testing for immunity, or an antibody test.
Merck & Co. Inc., Pfizer Inc., and Eli Lilly and Company announced medical service volunteer programs to enable employees who are licensed medical professionals to aid in the fight against COVID-19 while maintaining their base pay.
GRAIL published validation data for the company’s multi-cancer early detection blood test, which can detect more than 50 different cancer types across all stages.
A summary of daily biopharma industry news regarding the novel coronavirus trending on March 27, 2020, with the FDA now working with 220 test developers.
Roche Holding AG Chief Executive Officer Severin Schwan said in an interview with CNBC it could take at least a couple of weeks, if not months, for the United States to implement broad testing for coronavirus.
Scanwell Health secured exclusive rights to license and distribute a SARS-CoV-2 rapid serology test from INNOVITA for at-home use. The test takes 15 minutes to complete using the Scanwell Health app, and within hours a doctor or nurse practitioner will reach out with results and next steps.
The U.S. Food and Drug Administration approved Abbott’s molecular test for the novel coronavirus that causes COVID-19 under an Emergency Use Authorization (EUA).
As the number of diagnosed cases of COVID-19 continues to increase across the globe and more and more governments are urging citizens to self-quarantine, the pharmaceutical and life sciences industry continues to work toward the development of a vaccine and therapies for the respiratory infection that was declared a pandemic by the World Health Organization.
U.S. Vice President Mike Pence promised that Americans would have access in the days ahead to more than 2,000 laboratories capable of processing coronavirus tests, and a leading expert said the country would launch a new phase of testing for the fast-spreading disease.
The U.S. Food and Drug Administration granted Roche’s cobas SARS-CoV-2 Test Emergency Use Authorization.